Today, the Honourable Marjorie Michel, Minister of Health, accompanied by the Honourable Ginette Petitpas Taylor, Member of Parliament for Moncton—Dieppe, announced more than $78 million in funding over five years to seven organizations including five Atlantic post-secondary training institutions to improve access to health services in French for Francophone communities.
The Honourable Marjorie Michel, Minister of Health, accompanied by the Honourable Ginette Petitpas Taylor, Member of Parliament for Moncton—Dieppe, will make an important announcement to support access to health services in French for Francophone communities.
Today, the Honourable Marjorie Michel, Minister of Health, announced $2.8 million in funding from the Emergency Treatment Fund (ETF) to support four projects in Atlantic.
The Honourable Marjorie Michel, Minister of Health, will make an important announcement on helping to address the substance use and overdose crisis in the Atlantic Region.
Today, the Minister of Health, Marjorie Michel, launched a 45-day public consultation on proposed changes to how Canada regulates precursor chemicals and devices such as pill presses and encapsulators that could be used in the illegal production of drugs. The consultation is open until August 12, 2025.
Today, the Honourable Kamal Khera, Minister of Health, accompanied by the Honourable Ali Ehsassi, Minister of Government Transformation, Public Services and Procurement announced that all remaining eligible Canadians aged 18 to 64 years-old will be able to apply for the CDCP in May 2025; with coverage starting as early as June 1, 2025.
Today, the Honourable Kamal Khera, Canada’s Minister of Health, announced an agreement with Quebec investing over $305 million to support access to new and existing drugs, early diagnosis, and screening for rare diseases and Quebec’s Action Plan on Rare Diseases 2023-2027.
Today, the Honourable Kamal Khera, Canada’s Minister of Health, and the Honourable Michelle Thompson, Nova Scotia’s Minister of Health and Wellness, announced a bilateral agreement investing over $39 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.